MedTrace Logo

Mebendazole as Adjuvant Treatment for Colon Cancer

NCT03925662 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-04-24

No results posted yet for this study

Summary

mebendazole treating colon cancer

Conditions

Interventions

DRUG

Folfox with avastin

Folfox with avastin only

DRUG

Mebendazole

Folfox with avastin with mebendazole

Sponsors & Collaborators

  • Sherief Abd-Elsalam

    lead OTHER

Principal Investigators

  • Reham El-ghoneimy, Msc · Tanta University - Faculty of Pharmacy

  • Sahar Hegazy, Prof · Tanta University - Faculty of Pharmacy

  • Gamal el-azab, Prof · Tanta University - Faculty of Pharmacy

  • Fatma Zakaria, Prof · Tanta University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2028-12-31
Completion
2028-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03925662 on ClinicalTrials.gov